Digital PCR Market to Exhibit 17.2% CAGR by 2026 Owing to Improving Healthcare Facilities in Developing Nations, reports Fortune Business Insights™

    NEXT STORY
    Sun BioPharma Announces Pause in Enrollment of Clinical Trial of SBP-101 for Patients with Pancreatic Cancer
    PREV STORY
    SIGA Announces Award of First International Contract for Oral TPOXX® with Purchase by the Canadian Department of National Defence
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Interpace Diagnostics to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results and Business Progress on Monday November 13, 2017

    PARSIPPANY, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” ...

    author_avatar
    NASDAQ Market News

    Tiziana Life Sciences announces presentation of StemPrintER, a superior prognostic test as compared to Oncotype DX to predict breast cancer

    author_avatar
    NASDAQ Market News

    ContraFect to Present at 2017 Cantor Fitzgerald Global Healthcare Conference

    YONKERS, N.Y., Sept. 13, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company ...

    author_avatar
    NASDAQ Market News